Evofem Biosciences, Inc. Annual Income Tax Expense (Benefit) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Evofem Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2023.
  • Evofem Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $8K, a 167% increase year-over-year.
  • Evofem Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $17K, a 61.4% decline from 2022.
  • Evofem Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $44K, a 159% increase from 2021.
  • Evofem Biosciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $17K, a 325% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $17K -$27K -61.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $44K +$27K +159% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $17K +$13K +325% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-27
2020 $4K $0 0% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $4K +$2K +100% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $2K -$1K -33.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $3K +$616K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 -$613K -$613K Jan 1, 2016 Dec 31, 2016 8-K/A 2018-04-06
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2017-03-23
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.